What the Ebola Case Means for Mutual Fund Investors

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

Business news with 3-d bar charts on top

News

What the Ebola Case Means for Mutual Fund Investors

Shauna O'Brien Oct 01, 2014



What Ebola Means for Investors


Shares of Tekmira Pharmaceuticals (TKMR) have been surging as the company is now in clinical trials to create a drug for the virus. The company has been given approval by the FDA to give its TKM-Ebola drug to subjects “with confirmed or suspected Ebola virus infections.”

The recent U.S. case of Ebola in the U.S. also now has pharmaceutical companies racing to create a vaccine for the virus.

The companies involved in the treatment or vaccination of the virus range from small biotech companies to pharma giants like GlaxoSmithKline (GSK).


Mutual Funds to Watch



The Bottom Line


There are several mutual funds that offer specific exposure to these industries including the funds listed above.

Popular Articles

Download Our Free Report

Why 30 trillion is invested in mutual funds book